Patient Guide: A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 76 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05907122
Status: ACTIVE_NOT_RECRUITING
Condition: Melanoma
Phase: PHASE3

Where You Can Participate

This study is available at 76 locations across the country.

Top locations include:
  • • Long Beach, California
  • • Billings, Montana
  • • Mar Del Plata, Río Negro Province
  • • And 73 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma - Join Clinical Trial NCTNCT05907122

How to Join This Clinical Trial - NCTNCT05907122

Learn how to participate in this PHASE3 trial studying an investigational therapy for Melanoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Melanoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Melanoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05907122 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 76 locations. Find a study site near you:

Clinical Research Site

Long Beach, California 90806 - United States

Status: Contact for availability

Clinical Research Site

Billings, Montana 59102-6746 - United States

Status: Contact for availability

Clinical Research Site

Mar Del Plata, Río Negro Province 7600 - Argentina

Status: Contact for availability

Clinical Research Site

Sarajevo, Kanton Sarajevo 71000 - Bosnia and Herzegovina

Status: Contact for availability

Clinical Research Site

Banja Luka, Republika Srpska 78000 - Bosnia and Herzegovina

Status: Contact for availability

Clinical Research Site

Tuzla, Tuzlanski Kanton 75000 - Bosnia and Herzegovina

Status: Contact for availability

Clinical Research Site

Zenica, Zeničko-dobojski Kanton 72000 - Bosnia and Herzegovina

Status: Contact for availability

Clinical Research Site

Mostar, 88000 - Bosnia and Herzegovina

Status: Contact for availability

Clinical Research Site

Fortaleza, Ceará 60140-025 - Brazil

Status: Contact for availability

Clinical Research Site

Salvador, Estado de Bahia 41256900 - Brazil

Status: Contact for availability

And 66 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Melanoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships